Actinogen Limited (ASX: ACW) has now completed the consolidation of the Company’s securities on a 1:2 basis, and now has around 51.1 million shares on issue, and 9.1 million 30/9/2015 options exercisable at $0.40 each.
Trading on a normal T+3 settlement basis will kick off next Tuesday the 17th December 2013.
Actinogen has a unique company aim to identify and isolate soil microorganisms, known as actinomycetes, which are capable of producing bioactive compounds of commercial value.
There is the potential for actinomycetes to degrade industrial wastes such as oils, tar, domestic and industrial waste, and the rehabilitation of oil spills.
Actinogen is looking to collaborate with groups nationally and internationally in the development of technology that is synergistic with, or that could perhaps utilise, its current actinomycetes research projects and intellectual property.
Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX “Small and Mid-cap” stocks with distribution in Australia, UK, North America and Hong Kong / China.